CAROLYN GUIDO: Open Payments
NPI 1992262331 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 12 payments from 5 companies in 2025. Trend: 2023 $1,176 · 2024 $1,543 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $500 |
| Novo Nordisk Inc | 4 | $395 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $220 |
| Abbott Laboratories | 1 | $162 |
| Axsome Therapeutics, Inc. | 1 | $125 |
Products named: Wegovy, BREZTRI, AIRSUPRA, JARDIANCE, FREESTYLE LIBRE 3, Auvelity, Ozempic.
Industry payments across MO — which companies pay providers there.
